Adjuvant chemotherapy may be unnecessary for ypT0-2N0 gastric cancer patients after neoadjuvant chemotherapy and curative gastrectomy

Bibliographic Details
Published in:	Chinese Medical Journal
Main Authors:	Xinxin Shao, Fuhai Ma, Wenzhe Kang, Jianping Xiong, Haitao Hu, Weikun Li, Yibin Xie, Yantao Tian, Ting Gao, Xiuyuan Hao
Format:	Article
Language:	English
Published:	Wolters Kluwer 2023-08-01
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000002682

Similar Items

The role of adjuvant chemotherapy in rectal cancer patients with ypT0-2N0 after neoadjuvant chemoradiotherapy
by: Jianguo Yang, et al.
Published: (2024-02-01)

The Benefits of Adjuvant Chemotherapy for ypT3-4N0M0 Rectal Cancer Following Neoadjuvant Chemoradiation and Surgery
by: Chih-Hsien Chang, et al.
Published: (2025-07-01)

Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital
by: Christian Galata, et al.
Published: (2018-08-01)

Does postoperative chemotherapy improve overall survival of patients with ypT1-2N0 cancer?
by: Pengfei Su, et al.
Published: (2022-12-01)

A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?
by: Sebahattin Celik, et al.
Published: (2015-01-01)

Evaluation of cleaved caspase-3 and Ki-67 index on diagnostic biopsy in response to neoadjuvant chemotherapy in the context of post-treatment tumour ypT stage, ypN stage, grade, and molecular subtype
by: Vasil Nanev, et al.
Published: (2024-03-01)

The prognostic differences and the effect of postmastectomy radiotherapy between post‐chemotherapy ypT1‐2ypN1 and de novo pT1‐2N1 breast cancer
by: Tian Yang, et al.
Published: (2023-04-01)

A prospective study on using shear wave elastography to predict the ypT0 stage of rectal cancer after neoadjuvant therapy: a new support for the watch-and-wait approach?
by: Mengjia Liu, et al.
Published: (2024-04-01)

CD133 and CD166 Stem Cells Markers Expression, Clinicopathological Parameters, and Fragmentation Response Patterns of ypT3 Rectal Cancer Following Neoadjuvant Chemoradiotherapy
by: Diana Lavinia Pricope, et al.
Published: (2025-05-01)

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer.
by: Ippei Fukada, et al.
Published: (2016-01-01)

The impact of postmastectomy radiotherapy on cT1-2N1 breast cancer patients with ypN0 after neoadjuvant chemotherapy: a retrospective study based on real-world data
by: Yuran Dai, et al.
Published: (2023-01-01)

Clinical variables predicting T0 after neoadjuvant chemotherapy in bladder cancer
by: L. Di Gianfrancesco, et al.
Published: (2025-09-01)

Can Elevated Pretreatment Serum Carcinoembryonic Antigen Levels Serve as a Potential Biomarker Guiding Adjuvant Chemotherapy in Rectal Cancer Patients With ypTis-3N0 After Neoadjuvant Radiotherapy and Surgery?
by: Chi Huang, et al.
Published: (2021-08-01)

Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?
by: Fuhai Ma, et al.
Published: (2020-02-01)

Oncological risk of proximal gastrectomy for proximal advanced gastric cancer after neoadjuvant chemotherapy
by: Yonghe Chen, et al.
Published: (2024-02-01)

Prognostic Model of D2 Radical Gastrectomy Combined with Neoadjuvant Chemotherapy for Gastric Cancer
by: Wang G, et al.
Published: (2023-07-01)

Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study
by: Yuxin Zhong, et al.
Published: (2023-01-01)

Correction: Oncological risk of proximal gastrectomy for proximal advanced gastric cancer after neoadjuvant chemotherapy
by: Yonghe Chen, et al.
Published: (2024-03-01)

Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial
by: Maneesh Kumarsing Beeharry, et al.
Published: (2020-03-01)

A Modified ypTNM Staging System–Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy
by: Li Z, et al.
Published: (2020-03-01)

Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy
by: Shi Chen, et al.
Published: (2017-01-01)

Safety and efficacy of laparoscopic radical gastrectomy after neoadjuvant chemotherapy plus immunotherapy: a retrospective cohort study
by: Junjie Xiong, et al.
Published: (2025-09-01)

A case report of advanced gastric small cell carcinoma with neoadjuvant chemotherapy followed by radical total gastrectomy
by: Bing Wang, et al.
Published: (2020-12-01)

FLOT Neoadjuvant Chemotherapy Followed by Laparoscopic D2 Gastrectomy in the Treatment of Locally Resectable Advanced Gastric Cancer
by: Shun Zhang, et al.
Published: (2020-01-01)

Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
by: Ruiliang Chen, et al.
Published: (2024-12-01)

Axillary response and outcome in breast cancer patients after neoadjuvant treatment: The role of radiotherapy in reducing recurrence in ypN0 patients with initially cN+ stage
by: Xiaoqiu Ren, et al.
Published: (2023-04-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2007-03-01)

Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma
by: Khudair J. Sabeeh Al-Rawaq
Published: (2012-04-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Neoadjuvant chemotherapy for colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2022-06-01)

Curative effect of immediate reconstruction after neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis
by: Gang Li, et al.
Published: (2023-11-01)

Safety and Efficacy of Laparoscopic Versus Open Gastrectomy in Patients With Advanced Gastric Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis
by: Xu-Liang Liao, et al.
Published: (2021-08-01)

Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer
by: Selena J. An, et al.
Published: (2022-05-01)

Outcomes and Prognostic Factors of Patients with Urothelial Carcinoma Undergoing Radical Cystectomy and pT0 in the Final Histology Without Neoadjuvant Chemotherapy
by: Rodler S, et al.
Published: (2022-08-01)

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

Neoadjuvant chemotherapy in neonatal Wilms′ tumor
by: Ramesh K Reddy, et al.
Published: (2015-01-01)

Neoadjuvant chemotherapy impacts axillary lymph node positivity in early breast cancer (cT1-2N0M0) with negative axillary lymph nodes at diagnosis
by: Jinxiu Ma, et al.
Published: (2025-10-01)

Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status
by: Naohisa Kuriyama, et al.
Published: (2020-05-01)

Effect of Helicobacter pylori infection on survival outcomes of patients undergoing radical gastrectomy after neoadjuvant chemotherapy: a multicenter study in China
by: Qi-Chen He, et al.
Published: (2025-03-01)

Conditional Survival Rate of Patients Undergoing Gastrectomy with D2 Lymph Node Dissection After Neoadjuvant Chemotherapy: A Retrospective Study
by: Yang X, et al.
Published: (2025-03-01)